Read More Pharma Industry News Emergent BioSolutions’ ACAM2000 receives FDA approval for Mpox prevention Emergent BioSolutions Inc. (NYSE: EBS) has achieved a notable milestone with the U.S. Food and Drug Administration (FDA)… byPallavi MadhirajuSeptember 1, 2024